Xenetic Biosciences, Inc. announced that Ari Nagler resigned as the company's former sole officer and director. The company appointed new directors and executive officers as: Brian Richards as Director; M Scott Maguire as Chief Executive Officer, Director; Colin William Hill as Chief Financial Officer, Director; Firdaus Jal Dastoor as Director; and Artur Isaev as Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 USD | +0.25% | +1.75% | +18.26% |
May. 22 | Xenetic Biosciences, Inc. Announces Management Resignations | CI |
May. 22 | Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.26% | 6.29M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. Announces Management Changes